Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial DNA medicine.

Salvatore DiMauro1

  • 1Department of Neurology, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY 10032, USA. sd12@columbia.edu

Bioscience Reports
|May 8, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A United States-based patient-reported adult polyglucosan body disease registry: initial results.

Therapeutic advances in rare disease·2024
Same author

Time to harmonize mitochondrial syndrome nomenclature and classification: A consensus from the North American Mitochondrial Disease Consortium (NAMDC).

Molecular genetics and metabolism·2022
Same author

Visual memory failure presages conversion to MELAS phenotype.

Annals of clinical and translational neurology·2022
Same author

Whole-exome sequencing detects <i>PYGM</i> variants in two adults with McArdle disease.

Cold Spring Harbor molecular case studies·2022
Same author

GBE1-related disorders: Adult polyglucosan body disease and its neuromuscular phenotypes.

Journal of inherited metabolic disease·2020
Same author

Metabolic shift underlies recovery in reversible infantile respiratory chain deficiency.

The EMBO journal·2020
Same journal

Bacterial heteroresistance mechanisms, dynamics, and emerging diagnostic approaches.

Bioscience reports·2026
Same journal

Expression of Concern: Exosomes derived from circRNA Rtn4-modified BMSCs attenuate TNF-α-induced cytotoxicity and apoptosis in murine MC3T3-E1 cells by sponging miR-146a.

Bioscience reports·2026
Same journal

Evaluation of correlations between serum and urinary vitamin D metabolites using LC-MS/MS.

Bioscience reports·2026
Same journal

The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies.

Bioscience reports·2026
Same journal

A peripheral blood-based approach involving vimentin along with AURKA enabled efficient tracking of elusive Oct4/Sox2-expressing disseminated breast cancer stem cells.

Bioscience reports·2026
Same journal

MCM2-7 proteins promote NF-κB transcriptional activity through cooperative promoter recruitment.

Bioscience reports·2026
See all related articles

Mitochondrial DNA (mtDNA) mutations cause numerous human diseases. This review covers the genetics and clinical aspects of these disorders, focusing on protein synthesis and coding gene mutations.

Area of Science:

  • Mitochondrial genetics
  • Human genetics
  • Molecular medicine

Background:

  • Mitochondrial DNA (mtDNA) is maternally inherited and prone to pathogenic mutations.
  • Over 150 pathogenic point mutations and numerous rearrangements in mtDNA are linked to human diseases.
  • Mitochondrial disorders affect multiple systems or specific tissues.

Purpose of the Study:

  • To review the mitochondrial genetics of mtDNA-related disorders.
  • To describe the clinical features associated with mtDNA mutations.
  • To categorize mtDNA disorders based on affected genes.

Main Methods:

  • Literature review of mitochondrial genetics.
  • Analysis of clinical data for mtDNA-related diseases.
  • Classification of mutations affecting mitochondrial protein synthesis and protein-coding genes.

Related Experiment Videos

Main Results:

  • mtDNA mutations are a significant cause of human genetic disorders.
  • Disorders are broadly classified into two groups based on gene targets.
  • A wide spectrum of clinical presentations is associated with mtDNA defects.

Conclusions:

  • Understanding mtDNA genetics is crucial for diagnosing and managing mitochondrial diseases.
  • Further research into mtDNA mutation mechanisms and therapeutic strategies is warranted.
  • This review provides a comprehensive overview for clinicians and researchers in mitochondrial medicine.